Advanced Implantable Canister for Optimized Biotherapeutic Agent Delivery

An implantable canister with dynamically adjustable pore size, enhanced biocompatibility, and real-time monitoring capabilities for efficient delivery of cellular and biotherapeutic agents.

The original implantable cellular and biotherapeutic agent delivery canister patent (FIELD OF INVENTION) has limitations in terms of controlled agent release, biocompatibility, and adaptability to changing tissue environments. The new inventive concept addresses these limitations by introducing a dynamically adjustable pore size, nanoscale bicontinuous morphology for enhanced biocompatibility, and real-time monitoring capabilities.

The advanced implantable canister features a nanoporous structure with dynamically adjustable pore size, allowing for optimal agent release in response to changes in the surrounding tissue environment. The canister is fabricated using a 3D printing process, enabling customized, patient-specific pore structures. Additionally, the canister is coated with a nanoscale, bicontinuous morphology that promotes cellular adhesion and tissue integration, enhancing biocompatibility. A microfluidic channel integrated into the canister enables real-time monitoring of agent release and tissue response. Furthermore, the canister is designed with a self-healing mechanism that repairs damage to the nanoporous structure, ensuring optimal agent release.

The new claims introduce a dynamically adjustable pore size, nanoscale bicontinuous morphology, and real-time monitoring capabilities, which are not present in the original patent. These features provide a significant improvement in controlled agent release, biocompatibility, and adaptability to changing tissue environments, thereby constituting a non-obvious inventive step.

Alternative embodiments of the advanced implantable canister could include varying the material composition, incorporating additional sensors for real-time monitoring, or integrating with other implantable devices. Variations of the self-healing mechanism could also be explored, such as using different materials or geometries.

The advanced implantable canister has significant commercial potential in the biotechnology and pharmaceutical industries, particularly in the areas of regenerative medicine, tissue engineering, and personalized healthcare. Target markets include hospitals, research institutions, and pharmaceutical companies.